Highlights

  • The Healthy Chef products will launch across approximately 410 Priceline stores.
  • Stage One rollout begins in July 2026, with a potential second phase planned for early 2027.
  • Initial products include protein powders and nutritional supplements, including Metabolic Burn.
  • The rollout expands Elixinol's national retail presence while broader profitability remains under focus.

Elixinol Wellness Ltd (ASX:EXL) has secured a significant retail expansion for its Healthy Chef nutrition brand through a nationwide rollout across Priceline Pharmacy stores. The agreement broadens the company's retail distribution network beyond its established direct-to-consumer and specialty retail channels. While the expanded presence offers greater market exposure for the brand, the long-term financial impact will depend on customer demand and execution as the company continues working towards improving its overall operating performance.

Healthy Chef Secures Nationwide Priceline Distribution

Elixinol confirmed that The Healthy Chef products will be introduced into approximately 410 Priceline Pharmacy stores across Australia.

The first stage of the rollout is scheduled to commence during July 2026, with a second phase targeted for early 2027, subject to the performance of the initial launch.

Stage One includes a curated range of the brand's protein powders and powdered nutritional supplements, including Metabolic Burn, which has also received industry recognition through a Best New Product Development nomination at the Hive Awards.

The company stated that different merchandising formats will be used to suit varying Priceline store sizes across the network.

Retail Expansion Broadens Distribution Strategy

The Priceline agreement represents one of Elixinol's largest retail distribution initiatives for The Healthy Chef brand.

Historically, the business has generated sales through its own online channels together with selected health food retailers and specialty outlets.

Priceline's national footprint provides access to a broader customer base while complementing Elixinol's existing relationships with major retailers including Coles, Woolworths, Costco and Petstock across its wider product portfolio.

Management has indicated that the agreement supports its strategy of expanding business-to-business sales channels alongside direct consumer engagement.

Diversified Wellness Portfolio Continues to Evolve

Elixinol Wellness operates a portfolio of nutrition and wellness brands spanning multiple product categories.

Alongside The Healthy Chef, the company owns brands including Hemp Foods Australia, Mt Elephant, Field Day Pet, Soul Seed Hemp, Australian Primary Hemp, The Australian Superfood Co and Ananda Equine.

Its operations extend across nutritional supplements, hemp-based foods, baking products, pet nutrition and CBD-derived wellness products.

The group has spent recent years simplifying and integrating its portfolio while seeking to improve operating efficiency across its businesses.

Commercial Execution Remains the Next Focus

Although the Priceline rollout significantly increases retail exposure, Elixinol has not disclosed specific sales or earnings forecasts linked to the agreement.

The planned second stage of the rollout remains dependent on the commercial performance of Stage One.

As a result, future company updates are expected to provide greater insight into product sell-through, retail expansion and broader financial performance.

Investors are also likely to monitor how increased distribution contributes to revenue growth as the company continues working to reduce losses and strengthen its financial position.

What Investors May Watch

Investors may monitor sales performance following the Priceline rollout, progress towards the proposed second-stage expansion, financial results, retail partnerships and future ASX announcements.

Risks

Elixinol Wellness remains exposed to retail execution risk, consumer demand fluctuations, competitive wellness markets, funding requirements, margin pressure, inventory management challenges and the possibility that expanded distribution may not translate into sustained revenue growth.